期刊文献+

血清中ECP、IgE的表达水平及FEV_1的检测对支气管哮喘患儿的诊断意义 被引量:18

The Expression of ECP and IgE in Serum and Diagnostic Significance of the Detection of FEV1 in Children with Bronchial Asthma
下载PDF
导出
摘要 目的探讨血清嗜酸粒细胞阳离子蛋白(ECP)和免疫球蛋白(IgE)表达水平以及第1秒用力呼气流量(FEV1)的值与支气管哮喘之间的关系。方法采用变态反应法和双抗体夹心(ELISA)法分别检测80例急性发作期和缓解期哮喘患儿和30例健康儿血清中ECP、IgE的表达水平和FEV1的值。结果 哮喘发作期血清ECP、IgE表达水平显著高于稳定期、缓解期及健康对照组,但缓解期与稳定期差异无显著性,仍明显高于正常对照组。哮喘发作期FEV1水平显著低于稳定期、缓解期及健康对照组,但缓解期与稳定期差异无显著性,仍明显低于正常对照组。结论ECP、IgE在哮喘的急性发病中起着重要作用,其可能是构成气道慢性炎症的各类因素之一,同时气道阻塞越重,病情也越明显。联合测定血清ECP、IgE水平和FEV1水平有助于哮喘的诊断及判断病情。 Objective To discuss the expression of ECP and IgE and the relationship between FEV1 and bronchial asthma. Methods The expression level of ECP and IgE in serum and the value of FEV1 in 80 cases of acute and remission stage and 30 health children were detected by allergy method and ELISA, respectively. Results The expression level of ECP and IgE in attack stage was obviously higher than that in stable stage, remission stage and health control group. But the difference between stable stage and remission stage had no obvious difference, and they were still higher that of control group. The level of FEV1 in attack stage was significantly lower than that in stable stage, remission stage and health control group. But the difference between stable stage and remission stage had no obvious difference, and they were still higher that of control group. Conclusion ECP and IgE play an important part in the onset of asthma. It may be an factor for the occurrence of chronic airway inflammation. The disease is worsen with the severity of airway obstruction. The determination of the level of ECP, IgE and FEV1 is helpful to the diagnosis of asthma and evaluation of disease condition.
作者 郜芳丽
出处 《中国实验诊断学》 2012年第1期79-80,共2页 Chinese Journal of Laboratory Diagnosis
关键词 哮喘 ECP IGE FEV1 Asthma ECP IgE FEV1
  • 相关文献

参考文献8

二级参考文献50

  • 1李立文.粒细胞巨噬细胞集落刺激因子与哮喘非特异性炎症[J].国外医学(呼吸系统分册),1994,14(1):21-24. 被引量:11
  • 2邵耀明,谢国强,张明坤.支气管哮喘血清ECP检测的临床应用[J].实用医技杂志,2005,12(12B):3580-3582. 被引量:3
  • 3徐军.支气管哮喘发病机制研究新进展[J].中华结核和呼吸杂志,2007,30(7):490-493. 被引量:17
  • 4DOHERTY T, BROIDE D. Cytokines and growth factors in air- way remodeling in asthma[J]. Curr Opin Immunol, 2007, 19(6): 676-680.
  • 5BRIGHTLING C, BERRY M, AMRANI Y. Targeting TNF-alpha: a novel therapeutic approach for asthma [J]. J Allergy Clin Immunol, 2008, 121(1): 5-10.
  • 6BERRY M, BRIGHTLING C, PAVORD I, et al. TNF-alpha in asthma[J]. Curt Opin Pharmacol, 2007, 7(3): 279-282.
  • 7DALDEGAN MB, TEIXEIRA MM, TALVANI A, et al. Concentration of CCLll, CXCL8 and TNF-alpha in sputum and plasma of patients undergoing asthma or chronic obstructive pulmonary disease exacerbation[J]. Braz J Med Biol Res, 2005, 38 (9): 1359-1365.
  • 8VON GARNIER C, WIKSTROM ME, ZOSKY G, et al. Allergic airways disease develops after an increase in allergen capture and processing in the airway mucosa[J]. J Immunol, 2007, 179 (9): 5748-5759.
  • 9M. LAMPINEN, M. CARl.SON, L. D. HAKANSSON, et al. Cytokine-regulated accumulation of eosinophils in inflammatory disease[J]. Allergy, 2004, 59(8): 793-805.
  • 10BARNES PJ. Immunology of asthma and chronic obstructive pulmonary disease[J]. Nat Rev Immunol, 2008, 8(3): 183-192.

共引文献63

同被引文献131

引证文献18

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部